The European Federation of Pharmaceutical Industries and Associations (Efpia) and the International Diabetes Federation (IDF) invited PDGN to participate in a Diabetes and Covid event – “the potential of the digital transformation in diabetes care” event. With contributions from IDF, academia and Efpia, the conclusions were the need for accurate up to the minute data to guide decisions, and that data needs to be open to people to drive changes.
The lack of a European level database was identified, as was the failure to standardise national databases.